Ind-Swift Laboratories Limited will hold its 31st Annual General Meeting (AGM) on September 30, 2026, via Video Conferencing/Other Audio Visual Means (VC/OAVM). The meeting starts at 3:00 pm with the deemed venue at the company's registered office in Chandigarh.

The company submitted its annual report for the financial year 2025-26 (FY26) to the stock exchanges. The filing was made in compliance with Section 91 of the Companies Act, 2013 and Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Newspaper advertisements regarding the AGM notice and e-voting details were published in Financial Express and Jansatta on September 6, 2026.

Key Dates and Procedures

The cut-off date for determining voting entitlement is September 23, 2026. This aligns with Section 108 of the Companies Act, 2013 and Rule 20 of the Companies (Management and Administration) Rules, 2014.

Share transfer books will remain closed from September 24, 2026, to September 30, 2026. This closure facilitates the AGM process as mandated by regulatory guidelines.

Pardeep Verma, VP-Corporate Affairs & Company Secretary, signed the submission letter dated September 5, 2026. The notice includes procedures for remote e-voting before and during the meeting.

E-Voting Details

The Company has engaged Central Depository Services (India) Limited (CDSL) as the authorized agency for providing e-voting facility. The remote e-voting window is open for shareholders as on the cut-off date.

Members who have cast their vote by remote e-voting may attend the AGM but are not entitled to vote again. Once a vote is cast, it cannot be changed. Members attending via VC/OAVM will be counted for quorum purposes. Proxy appointment is not available for this meeting.

Agenda Items

The AGM agenda includes ordinary and special business items critical to corporate governance and board composition.

Ordinary Business

1. To receive, consider, approve and adopt the Audited Financial Statements (including Consolidated Financial Statements) for the financial year ended March 31, 2026, along with Directors' and Auditors' Reports.
2. To appoint Sh. Navrattan Munjal, Chairman & Whole-Time Director (DIN: 00015096), who retires by rotation under the Companies Act, 2013 and offers himself for re-appointment.

Special Business

1. Ratification of Cost Auditor Remuneration: Members will ratify the remuneration payable to M/s. V. Kumar & Associates, Cost Accountants, for the financial year 2026-27. The approved remuneration is up to ₹2,00,000 per annum plus applicable taxes and out-of-pocket expenses.
2. Appointment of Independent Director: Members will consider the appointment of Sh. Amit Mathur (DIN: 11916517) as an Independent Director. He was appointed as an Additional Director effective September 3, 2026. The proposed term is five years, ending September 2, 2031, and he will not be liable to retire by rotation.

Director Profiles

Sh. Navrattan Munjal

Sh. Navrattan Munjal serves as Chairman & Whole-Time Director. He has over four decades of experience in manufacturing and industrial sectors, with expertise in plant operations, production management, and strategic planning. His term ends on March 22, 2028, as per the postal ballot resolution passed on April 30, 2026. He holds 10,12,479 shares in the company.

Sh. Amit Mathur

Sh. Amit Mathur brings over three decades of experience in banking and financial services. He holds an MBA from IIM Kolkata and has held senior positions at Allahabad Bank, IDBI Bank, Axis Bank, and AU Small Finance Bank. His expertise includes corporate banking, credit management, enterprise risk management, and regulatory compliance. He will receive sitting fees for attending Board and committee meetings, along with reimbursement of actual travelling and other expenses.

Ind-Swift Laboratories has fixed the issue price for its preferential allotment of warrants at ₹196 each. The Preferential Issue Committee approved the pricing during a meeting held on September 4, 2026, following shareholder approval at an Extra-Ordinary General Meeting on August 5, 2026.

The final issue price exceeds both the regulatory floor price and the independent valuation estimate. Under Regulation 164 of the SEBI ICDR Regulations, 2018, the minimum floor price was determined to be ₹195.98, based on the higher of the 90-day volume-weighted average price (₹154.48) and the 10-day volume-weighted average price (₹195.98) preceding the relevant date of July 6, 2026.

Pricing Methodology

The company followed a multi-step pricing framework mandated by SEBI regulations due to the issuance representing more than five percent of the post-issue fully diluted share capital. The final price was derived from three distinct benchmarks:

An independent valuation report by Corporate Professionals Valuation Services Private Limited placed the warrant value at ₹189.46. However, SEBI Regulation 166A requires the minimum issue price to be the higher of the price determined under Regulation 164 or the valuation report. Consequently, the regulatory floor stood at ₹195.98.

What the Numbers Show

The board’s decision to set the issue price at ₹196 represents a premium of just ₹0.02 over the strict regulatory floor. This minimal margin suggests the company prioritized compliance efficiency and investor certainty over maximizing immediate capital raise per unit, likely to ensure swift allotment completion. The significant divergence between the 90-day average (₹154.48) and the 10-day average (₹195.98) indicates notable volatility in the stock’s trading price leading up to the relevant date, with recent trading activity driving the floor price significantly higher than longer-term trends.

All other particulars in the Explanatory Statement to the EGM Notice remain unchanged. The company is listed on the National Stock Exchange of India Limited and BSE Limited.